 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that AUPH's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Aurinia Pharmaceuticals (AUPH, $9.04) Stochastic Oscillator left the overbought zone on November 22, 2023

This is a signal that AUPH's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Aurinia Pharmaceuticals (AUPH, $8.74) RSI Indicator left the overbought zone on November 21, 2023

This price move could be a signal that AUPH may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Aurinia Pharmaceuticals (AUPH, $9.25) price may drop as it broke higher Bollinger Band on Nov 20, 2023

Aurinia Pharmaceuticals (AUPH, $9.25) RSI Indicator left the overbought zone on November 20, 2023

Aurinia Pharmaceuticals (AUPH, $8.6) Stochastic Oscillator left the overbought zone on November 17, 2023

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Aurinia Pharmaceuticals Inc (AUPH), where a total volume of 11,358 contracts has...

Notable Wednesday Option Activity: AUPH, PSX, UTI

This price move could indicate a change in the trend, and may be a buy signal for investors...

Aurinia Pharmaceuticals (AUPH, $8.17) price moved above its 50-day Moving Average on November 14, 2023

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Companys collaboration partner, Otsuka Pharmaceutical Ltd., filed a new drug application (NDA) for...

Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS (Voclosporin) in Japan

Aurinia Pharmaceuticals (AUPH, $7.58) Stochastic Oscillator left the overbought zone on November 09, 2023

Aurinia Pharmaceuticals (AUPH, $8.29) Stochastic Oscillator left the overbought zone on November 06, 2023

Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Watchers	43,808
52-Wk Low	$4.07
52-Wk High	$12.43

Market Cap	$1.23B
Volume (M)	2.22M
52-Wk High	$12.43
52-Wk Low	$4.07

AUPH Aurinia Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals